Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1991 2
1992 1
1994 6
1995 2
1996 1
1997 3
1998 1
1999 1
2000 1
2003 1
2004 4
2005 1
2006 5
2007 7
2008 11
2009 7
2010 7
2011 12
2012 8
2013 2
2014 5
2015 8
2016 3
2017 6
2018 4
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
Not all patients with a diagnosis of a radial scar require excision.
Eghtedari M, Le-Petross H, Babiera GV, Albarracin CT, Hess KR, Woodtichartpreecha P, Whitman GJ. Eghtedari M, et al. Among authors: Albarracin CT. Breast J. 2019 Jul;25(4):792-794. doi: 10.1111/tbj.13329. Epub 2019 May 13. Breast J. 2019. PMID: 31087426 No abstract available.
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.
Basho RK, Yam C, Gilcrease M, Murthy RK, Helgason T, Karp DD, Meric-Bernstam F, Hess KR, Valero V, Albarracin C, Litton JK, Chavez-MacGregor M, Hong D, Kurzrock R, Hortobagyi GN, Janku F, Moulder SL. Basho RK, et al. Among authors: Albarracin C. Oncologist. 2018 Nov;23(11):1300-1309. doi: 10.1634/theoncologist.2017-0498. Epub 2018 Aug 23. Oncologist. 2018. PMID: 30139837 Free PMC article.
DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.
Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK. Kuerer HM, et al. Among authors: Albarracin C. J Cancer. 2017 Aug 22;8(14):2653-2662. doi: 10.7150/jca.20871. eCollection 2017. J Cancer. 2017. PMID: 28928852 Free PMC article. Review.
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer.
Asik E, Akpinar Y, Caner A, Kahraman N, Guray T, Volkan M, Albarracin C, Pataer A, Arun B, Ozpolat B. Asik E, et al. Among authors: Albarracin C. Nanomedicine (Lond). 2019 Sep;14(17):2315-2338. doi: 10.2217/nnm-2019-0132. Epub 2019 Aug 21. Nanomedicine (Lond). 2019. PMID: 31432749
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Clifton K, Gutierrez-Barrera A, Ma J, Bassett R Jr, Litton J, Kuerer H, Moulder S, Albarracin C, Hortobagyi G, Arun B. Clifton K, et al. Among authors: Albarracin C. Breast Cancer Res Treat. 2018 Jul;170(1):101-109. doi: 10.1007/s10549-018-4727-9. Epub 2018 Feb 22. Breast Cancer Res Treat. 2018. PMID: 29470805 Free PMC article.
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab.
Basho RK, Gilcrease M, Murthy RK, Helgason T, Karp DD, Meric-Bernstam F, Hess KR, Herbrich SM, Valero V, Albarracin C, Litton JK, Chavez-MacGregor M, Ibrahim NK, Murray JL 3rd, Koenig KB, Hong D, Subbiah V, Kurzrock R, Janku F, Moulder SL. Basho RK, et al. Among authors: Albarracin C. JAMA Oncol. 2017 Apr 1;3(4):509-515. doi: 10.1001/jamaoncol.2016.5281. JAMA Oncol. 2017. PMID: 27893038 Clinical Trial.
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.
Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM. Tadros AB, et al. Among authors: Albarracin CT. Ann Surg. 2019 Jan;269(1):150-157. doi: 10.1097/SLA.0000000000002439. Ann Surg. 2019. PMID: 28742682 Free PMC article.
Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.
Karbasian N, Sohrabi S, Omofoye TS, Le-Petross H, Arun BK, Albarracin CT, Hess KR, Gutierrez-Barrera AM, Whitman GJ. Karbasian N, et al. Among authors: Albarracin CT. Curr Probl Diagn Radiol. 2020 Jan 8:S0363-0188(20)30016-5. doi: 10.1067/j.cpradiol.2020.01.011. Online ahead of print. Curr Probl Diagn Radiol. 2020. PMID: 32033821 Review.
Pseudoangiomatous Stromal Hyperplasia of the Breast: Multimodality Review With Pathologic Correlation.
Raj SD, Sahani VG, Adrada BE, Scoggins ME, Albarracin CT, Woodtichartpreecha P, Posleman Monetto FE, Whitman GJ. Raj SD, et al. Among authors: Albarracin CT. Curr Probl Diagn Radiol. 2017 Mar-Apr;46(2):130-135. doi: 10.1067/j.cpradiol.2016.01.005. Epub 2016 Feb 2. Curr Probl Diagn Radiol. 2017. PMID: 26949063 Review.
100 results
Jump to page
Feedback